Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

1-23 of 23 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

Efficacy of clozapine versus standard treatment in adult individuals with intellectual disability and treatment-resistant psychosis (CLOZAID): study protocol of a multicenter randomized clinical trial.
Alemany-Navarro M, Sánchez-Barbero B, Reguera-Pozuelo P, Altea-Manzano L, Gómez-Garrido A, Rocha-González I, Garrido-Torres N, Ruiz-Veguilla M, García-Cerro S, Rosso-Fernández CM, Villagrán-Moreno JM, Sarramea F, Cervilla-Ballesteros J, Martínez-Leal R, Mayoral-Cleries F, CLOZ-AID Group, Crespo-Facorro B
Front Psychiatry, 15:1400621, 14 May 2024
Cited by: 0 articles | PMID: 38807685 | PMCID: PMC11130499
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Exploring genetic testing requests, genetic alterations and clinical associations in a cohort of children with autism spectrum disorder.
Garrido-Torres N, Marqués Rodríguez R, Alemany-Navarro M, Sánchez-García J, García-Cerro S, Ayuso MI, González-Meneses A, Martinez-Mir A, Ruiz-Veguilla M, Crespo-Facorro B
Eur Child Adolesc Psychiatry, 08 Apr 2024
Cited by: 0 articles | PMID: 38587680
Add to export list
Exploratory Analysis of MicroRNA Alterations in a Neurodevelopmental Mouse Model for Autism Spectrum Disorder and Schizophrenia.
García-Cerro S, Gómez-Garrido A, Garcia G, Crespo-Facorro B, Brites D
Int J Mol Sci, 25(5):2786, 28 Feb 2024
Cited by: 1 article | PMID: 38474035 | PMCID: PMC10932205
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Exploring Genetic Testing Requests, Genetic Alterations and Clinical Associations in a Cohort of Children with Autism Spectrum Disorder
Garrido-Torres N, Rodríguez RM, Alemany-Navarro M, Sánchez-García J, García-Cerro S, Ayuso MI, González-Meneses A, Martinez-Mir A, Crespo-Facorro B, Ruiz-Veguilla M
Research Square, 21 Nov 2023
Cited by: 0 articles | PPR: PPR762953
Add to export list Preprint v1
Examining the immune signatures of SARS-CoV-2 infection in pregnancy and the impact on neurodevelopment: Protocol of the SIGNATURE longitudinal study.
Garrido-Torres N, Cerrillos L, García Cerro S, Pérez Gómez A, Canal-Rivero M, de Felipe B, Alameda L, Marqués Rodríguez R, Anillo S, Praena J, Duque Sánchez C, Roca C, Paniagua M, López Díaz A, Romero-García R, Olbrich P, Puertas Albarracín MP, Reguera Pozuelo P, Sosa IL, [...] Ruiz-Veguilla M
Front Pediatr, 10:899445, 21 Dec 2022
Cited by: 1 article | PMID: 36619503 | PMCID: PMC9811261
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
miRNAs as biomarkers of autism spectrum disorder: a systematic review and meta-analysis.
Garrido-Torres N, Guzmán-Torres K, García-Cerro S, Pinilla Bermúdez G, Cruz-Baquero C, Ochoa H, García-González D, Canal-Rivero M, Crespo-Facorro B, Ruiz-Veguilla M
Eur Child Adolesc Psychiatry, 33(9):2957-2990, 03 Feb 2023
Cited by: 5 articles | PMID: 36735095 | PMCID: PMC11424746
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Bexarotene Impairs Cognition and Produces Hypothyroidism in a Mouse Model of Down Syndrome and Alzheimer's Disease.
Vidal V, Puente A, García-Cerro S, García Unzueta MT, Rueda N, Riancho J, Martínez-Cué C
Front Pharmacol, 12:613211, 15 Apr 2021
Cited by: 5 articles | PMID: 33935706 | PMCID: PMC8082148
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Early postnatal oleic acid administration enhances synaptic development and cognitive abilities in the Ts65Dn mouse model of Down syndrome.
Vidal V, García-Cerro S, Rueda N, Puente A, Bartesaghi R, Martínez-Cué C
Nutr Neurosci, 25(7):1400-1412, 21 Dec 2020
Cited by: 2 articles | PMID: 33345728
Add to export list
Prenatal, but not Postnatal, Curcumin Administration Rescues Neuromorphological and Cognitive Alterations in Ts65Dn Down Syndrome Mice.
Rueda N, Vidal V, García-Cerro S, Puente A, Campa V, Lantigua S, Narcís O, Bartesaghi R, Martínez-Cué C
J Nutr, 150(9):2478-2489, 01 Sep 2020
Cited by: 5 articles | PMID: 32729926
Add to export list
Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptoms.
Boloc D, Rodríguez N, Torres T, García-Cerro S, Parellada M, Saiz-Ruiz J, Cuesta MJ, Bernardo M, Gassó P, Lafuente A, Mas S, Arnaiz JA
Psychopharmacology (Berl), 237(7):2151-2159, 07 May 2020
Cited by: 2 articles | PMID: 32382784
Add to export list
The positive allosteric modulator of the mGlu2 receptor JNJ-46356479 partially improves neuropathological deficits and schizophrenia-like behaviors in a postnatal ketamine mice model.
Martínez-Pinteño A, García-Cerro S, Mas S, Torres T, Boloc D, Rodríguez N, Lafuente A, Gassó P, Arnaiz JA, Parellada E
J Psychiatr Res, 126:8-18, 26 Apr 2020
Cited by: 4 articles | PMID: 32407891
Add to export list
Prenatal Administration of Oleic Acid or Linolenic Acid Reduces Neuromorphological and Cognitive Alterations in Ts65dn Down Syndrome Mice.
García-Cerro S, Rueda N, Vidal V, Puente A, Campa V, Lantigua S, Narcís O, Velasco A, Bartesaghi R, Martínez-Cué C
J Nutr, 150(6):1631-1643, 01 Jun 2020
Cited by: 8 articles | PMID: 32243527
Add to export list
Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics.
Boloc D, Gortat A, Cheng-Zhang JQ, García-Cerro S, Rodríguez N, Parellada M, Saiz-Ruiz J, Cuesta MJ, Gassó P, Lafuente A, Bernardo M, Mas S
Transl Psychiatry, 9(1):145, 02 May 2019
Cited by: 0 articles | PMID: 31048679 | PMCID: PMC6497654
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics.
Boloc D, Gortat A, Cheng-Zhang JQ, García-Cerro S, Rodríguez N, Parellada M, Saiz-Ruiz J, Cuesta MJ, Gassó P, Lafuente A, Bernardo M, Mas S
Transl Psychiatry, 8(1):276, 13 Dec 2018
Cited by: 11 articles | PMID: 30546092 | PMCID: PMC6293322
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice.
Rueda N, Vidal V, García-Cerro S, Narcís JO, Llorens-Martín M, Corrales A, Lantigua S, Iglesias M, Merino J, Merino R, Martínez-Cué C
Brain Behav Immun, 73:235-251, 31 May 2018
Cited by: 14 articles | PMID: 29758264
Add to export list
Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome.
Corrales A, Parisotto EB, Vidal V, García-Cerro S, Lantigua S, Diego M, Wilhem Filho D, Sanchez-Barceló EJ, Martínez-Cué C, Rueda N
Behav Brain Res, 334:142-154, 23 Jul 2017
Cited by: 8 articles | PMID: 28743603
Add to export list
Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder.
Rodríguez N, Morer A, González-Navarro EA, Serra-Pages C, Boloc D, Torres T, García-Cerro S, Mas S, Gassó P, Lázaro L, Lázaro L
J Neuroinflammation, 14(1):261, 28 Dec 2017
Cited by: 28 articles | PMID: 29284508 | PMCID: PMC5746006
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene.
García-Cerro S, Vidal V, Lantigua S, Berciano MT, Lafarga M, Ramos-Cabrer P, Padro D, Rueda N, Martínez-Cué C
Neurobiol Dis, 110:206-217, 05 Dec 2017
Cited by: 9 articles | PMID: 29221819
Add to export list
Decreasing the Expression of GABA_A α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome.
Vidal V, García-Cerro S, Martínez P, Corrales A, Lantigua S, Vidal R, Rueda N, Ozmen L, Hernández MC, Martínez-Cué C
Mol Neurobiol, 55(6):4745-4762, 17 Jul 2017
Cited by: 11 articles | PMID: 28717969
Add to export list
Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S, Rueda N, Vidal V, Lantigua S, Martínez-Cué C
Neurobiol Dis, 106:76-88, 21 Jun 2017
Cited by: 48 articles | PMID: 28647555
Add to export list
Microarray gene-expression study in fibroblast and lymphoblastoid cell lines from antipsychotic-naïve first-episode schizophrenia patients.
Gassó P, Mas S, Rodríguez N, Boloc D, García-Cerro S, Bernardo M, Lafuente A, Parellada E
J Psychiatr Res, 95:91-101, 05 Aug 2017
Cited by: 8 articles | PMID: 28822801
Add to export list
Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome.
Parisotto EB, Vidal V, García-Cerro S, Lantigua S, Wilhelm Filho D, Sanchez-Barceló EJ, Martínez-Cué C, Rueda N
Neurochem Res, 41(11):2904-2913, 23 Jul 2016
Cited by: 18 articles | PMID: 27450081
Add to export list
Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome.
García-Cerro S, Martínez P, Vidal V, Corrales A, Flórez J, Vidal R, Rueda N, Arbonés ML, Martínez-Cué C
PLoS One, 9(9):e106572, 04 Sep 2014
Cited by: 51 articles | PMID: 25188425 | PMCID: PMC4154723
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-23 of 23 results

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

Efficacy of clozapine versus standard treatment in adult individuals with intellectual disability and treatment-resistant psychosis (CLOZAID): study protocol of a multicenter randomized clinical trial.

Exploring genetic testing requests, genetic alterations and clinical associations in a cohort of children with autism spectrum disorder.

Exploratory Analysis of MicroRNA Alterations in a Neurodevelopmental Mouse Model for Autism Spectrum Disorder and Schizophrenia.

Exploring Genetic Testing Requests, Genetic Alterations and Clinical Associations in a Cohort of Children with Autism Spectrum Disorder

Examining the immune signatures of SARS-CoV-2 infection in pregnancy and the impact on neurodevelopment: Protocol of the SIGNATURE longitudinal study.

miRNAs as biomarkers of autism spectrum disorder: a systematic review and meta-analysis.

Bexarotene Impairs Cognition and Produces Hypothyroidism in a Mouse Model of Down Syndrome and Alzheimer's Disease.

Early postnatal oleic acid administration enhances synaptic development and cognitive abilities in the Ts65Dn mouse model of Down syndrome.

Prenatal, but not Postnatal, Curcumin Administration Rescues Neuromorphological and Cognitive Alterations in Ts65Dn Down Syndrome Mice.

Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptoms.

The positive allosteric modulator of the mGlu2 receptor JNJ-46356479 partially improves neuropathological deficits and schizophrenia-like behaviors in a postnatal ketamine mice model.

Prenatal Administration of Oleic Acid or Linolenic Acid Reduces Neuromorphological and Cognitive Alterations in Ts65dn Down Syndrome Mice.

Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics.

Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics.

Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice.

Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome.

Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder.

Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene.

Decreasing the Expression of GABA_A α5 Subunit-Containing Receptors Partially Improves Cognitive, Electrophysiological, and Morphological Hippocampal Defects in the Ts65Dn Model of Down Syndrome.

Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.

Microarray gene-expression study in fibroblast and lymphoblastoid cell lines from antipsychotic-naïve first-episode schizophrenia patients.

Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome.

Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome.

Partnerships & funding